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Abstract 20 
Biopesticides based on Bacillus thuringiensis kurstaki (Btk) and israelensis (Bti) spores and toxins 21 
are widely used to control insect pests, increasing environmental risks to non-target biodiversity. 22 
Here, we tested for potential effects of larval ingestion of Bt commercial formulations on 23 
Drosophila species. Doses equivalent to those recommended for field application (⩽106 CFU/g of 24 
fly medium) had no effect whereas Btk doses 10 to 100-fold higher (107-108 CFU/g) altered the 25 
development (decreased emergence due to larval mortality and increased development time), and 26 
moderately influenced adult fitness-related traits. At the highest Btk and Bti dose (109 CFU/g), all 27 
larvae died before pupation. The impact of Btk formulations resulted from the spores/cleaved toxins 28 
synergy, but also additives. While recommended doses had no effect on non-target Drosophila 29 
species, the accumulation of Bt bioinsecticides in the environment could have adverse side-effects 30 
on the populations of these species and therefore their associated communities.   31 
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Introduction 32 
The world's population is expected to reach more than 9 billion people by 2050 (United Nations, 33 
2015), increasing the demand for agricultural resources in the future. Increasing agricultural 34 
production requires improved management of pests, especially insects that cause more than 30% of 35 
losses (Pimentel and Burgess, 2014). Nowadays, their management still largely relies on 36 
conventional chemical insecticides. However, their use and efficiency have been considerably 37 
reduced due to the emergence of pests’ resistance, development of secondary pests, adverse side-38 
effects on non-target species (natural enemies of pests, pollinators) (Devine and Furlong, 2007; 39 
Sanchis and Bourguet, 2008), and more generally the impacts on biodiversity and human health (e.g. 40 
neurological disorders, functional impairment of reproduction, cancers) (WHO Report, 2007; Baldi 41 
et al. 2013; Gilden et al. 2016; Rizzati et al. 2016). Developed as an alternative, biopesticides are 42 
considered more specific and safer for the environment and human health. Today, they still 43 
represent less than 5% of the pesticide market, the large majority being microbial insecticide 44 
formulations based on viable spores and toxins of Bacillus thuringiensis (Bt) (over 400 registered 45 
formulations) (Sanchis and Bourguet, 2008; Lacey et al. 2015).  46 
Bt is a Gram-positive endospore-forming bacterium that synthesizes a wide range of toxins 47 
with different chemical structures, modes of action and biological targets. The most abundant and 48 
studied are Cry δ-endotoxins encoded by genes located on large plasmids and produced as 49 
parasporal crystalline inclusions during the stationary growth phase (Crickmore 2017, Adang et al. 50 
2014). Bt produces other insecticidal toxins, the Cyt (cytolytic δ-endotoxins) and Vip (secreted 51 
Vegetative Insecticidal Proteins) that synergize their effects with Cry toxins, virulence factors such 52 
as β-exotoxins (or thuringiensin), a secreted nucleotide toxic for almost all tested life forms thus 53 
prohibited in commercial formulations (WHO Report, 1999), and anti-fungal factors (Bravo et al. 54 
2017; Rabinovitch et al. 2017). Bt subspecies and strains can differ in their plasmid number and in 55 
the synthesized toxins cocktail responsible for their biological activity, which was used to delineate 56 
potential target insects (Palma et al. 2014). For instance, Bt subsp. kurstaki (Btk) produces the 5 Cry 57 
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toxins, Cry1Aa, Cry1Ab, Cry1Ac, Cry2Aa and Cry2Ab (Ben-Dov et al. 1997; Adang et al. 2014), 58 
while Bt subsp. israelensis (Bti) produces a combination of Cry4Aa, Cry4Ba, Cry10Aa, and 59 
Cry11Aa (Ben-Dov et al. 1999; Berry et al. 2002), both strains being commercially used. The 60 
different toxin cocktails produced by some Bt subspecies can also be harmful to non-insect 61 
organisms such as nematodes and protozoa (Palma et al. 2014). 62 
The formulations based on spores and toxin crystals of Btk and Bti are the most sprayed in 63 
organic farming and natural areas (e.g. forests, swamps) to deal with larvae of Lepidopteran pests 64 
and Dipteran larvae of mosquitoes and black flies, respectively. It is generally accepted that once 65 
ingested by insect larvae, the toxin crystals are dissolved by the midgut alkaline pH, releasing ~130 66 
kDa pro-toxins that are then processed by digestive proteases into smaller, soluble, active toxin 67 
fragments of ~ 60-70 kDa (Bravo et al. 2007; Wei et al. 2016). Active toxins bind to specific 68 
receptors of midgut epithelial cells, eliciting pores formation in the cell membrane, cell lysis and 69 
gut epithelium disorganization (Schnepf et al. 1998; Bravo et al. 2011). This allows gut bacteria, 70 
including Bt, to colonize the hemocoel, and leads to rapid septicaemia and death (Obata et al. 2009; 71 
Caccia et al. 2016).  72 
The increasing use of Bt has recently raised concern about its potential impact on non-target 73 
species. Numerous impact studies of field application rates and acute intoxications have concluded 74 
that Bt is safe or has a limited impact on non-target vertebrates and invertebrates, and associated 75 
species communities (Glare and O’Callaghan, 2000). Yet, there is growing evidence of direct and 76 
indirect cross-effects of Bt formulations and toxins across insect species and orders, or even across 77 
phyla, suggesting that Bt targeting is only partly specific (van Frankenhuyzen 2017; Venter and 78 
Bøhn, 2016). In addition, data showed that almost all of the Btk was still present on the leaves 79 
surface 72 hours after spraying (Bizzarri and Bishop, 2008), its amount returning close to 80 
environmental levels only 28 days after treatment (Raymond et al. 2010). Finally, Bt spores can 81 
survive in the soil and different supports for months and even years after application (Hendriksen et 82 
al. 2002; Duchet et al. 2014; Hung et al. 2016a, b; Enger et al. 2018). Bt formulations contain also 83 
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numerous compounds to protect spores and crystals and aggregate them into a wettable form, 84 
surfactants to facilitate spraying and dispersion on plants, and phagostimulants (Couch, 2000; Brar 85 
et al. 2006). Nevertheless, spores and toxins are somewhat sensitive to biotic and abiotic conditions 86 
(e.g. UV, pH, rainfall), which requires frequent applications to achieve the required pest control 87 
level (Brar et al. 2006). All this can lead to Bt accumulation in the environment, thus raising the 88 
rarely addressed issue of potential side-effects of chronic exposure (i.e. continuous and increasing 89 
exposure for an extended period) of non-target species to doses unexpectedly above the 90 
recommended application rates.  91 
Diptera are worldwide distributed insects, most of which are not targets for Bt and its toxins. 92 
This is the case of the genus Drosophila, represented by ~ 1500 described species (Bächli, 1999-93 
2008), including the model organism D. melanogaster. In the field, most of these flies feed and 94 
reproduce mainly on ripening or rotting fruits and are therefore present in areas treated with Bt such 95 
as orchards, vineyards and gardening areas. Unable to disperse between food patches, early stages 96 
of Drosophila larvae eat intensively and grow exponentially (Tennessen and Thumel, 2011), and 97 
may thus ingest high doses of Bt bioinsecticides. Surprisingly, few studies have focused on 98 
Drosophila species (Benz and Perron, 1967; Saadoun et al. 2001; Khyami-Horani 2002; Obeidat 99 
2008; Obeidat et al. 2012; Cossentine et al. 2016; Biganski et al. 2017; Haller et al. 2017) and most 100 
of them showed susceptibility of these species to Btk. However, definitive conclusions were 101 
difficult to draw since most of these studies used mainly late 3rd instar larvae preparing for pupation, 102 
i.e. when they feed much less than younger larvae, and the tested Bt preparations possibly contain 103 
highly toxic β-exotoxins, especially in the case of field isolates.  104 
Here, we have tested the dose-dependent chronic side-effects of different commercial 105 
formulations of Btk (devoid of β-exotoxins) and, to a lesser extent of Bti, on the wild-type D. 106 
melanogaster Canton S, with a focus on developmental traits (developmental time, emergence rate). 107 
The spore-forming Gram-positive Bacillus subtilis and the Btk strain (4D22), devoid of Cry toxin 108 
genes and thus of crystals, were used as non-pathogenic controls. We also analysed two fitness-109 
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related traits of adult flies (male and female longevity, offspring number) after entire development 110 
in presence of Btk formulation. To test for effects specific to the fly genetic background, 111 
developmental traits upon exposure to Btk formulation were also measured on several other D. 112 
melanogaster strains. Finally, we extended further these development experiments to several other 113 
Drosophila species, including cosmopolitan species and the invasive D. suzukii, which are 114 
frequently present in Bt treated areas, to explore the potential implications of chronic exposure to 115 
Btk formulation in terms of competition and associated communities.  116 
 117 
Results 118 
Btk formulations adversely impact the development of D. melanogaster.  119 
The wild-type Canton S strain of D. melanogaster was used to evaluate the dose-dependent effect 120 
of the commercial Btk formulation Delfin® A on the emergence rate (ER, proportion of emerged 121 
flies from the initial egg pool) and developmental time (DT, mean number of days from egg to adult 122 
emergence). Eggs were transferred on a standard low-protein/high-sugar fly medium containing 123 
Delfin® A at doses ranging from 5×105 CFU/g of medium (mean equivalent of the maximum 124 
recommended doses for field application; see Methods and Supplementary information S1) to 109 125 
CFU/g (~ 1,000 times the recommended dose). To check for specific effects of Btk formulations 126 
and the respective role of Btk spores and Cry toxins, we tested the same dose range of the 127 
commercial Bti formulation Vectobac® targeting mosquitoes that contains different Cry toxins 128 
(Bravo et al. 2011), of the Cry-free strain Btk 4D22, and of the Drosophila non-pathogenic spore-129 
forming Bacillus subtilis.  130 
Developmental traits (ER and DT) of exposed and non-exposed control flies were similar at 131 
doses up to 107 CFU/g of Delfin® A (Fig. 1a-b; Table 1). At higher doses, both ER and DT were 132 
affected in a dose-dependent manner: ER was reduced by 17% at 5×107 CFU/g (although not 133 
statistically significant), up to 100% at 109 CFU/g, dose at which no individual reached the pupal 134 
stage. The lethal dose 50 (LD50) was estimated between 5×107 and 108 CFU/g (Fig. 1a). DT was 135 
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increased of about 0.5 day at 5×107 CFU/g (+4% compared to controls), up to 1.5 days (+14%) at 136 
108 CFU/g (Fig. 1b; Table 1). The sex-ratio at emergence (SR, proportion of males) was strongly 137 
biased towards males at the highest dose at which complete development occurred (108 CFU/g), 138 
with 58% more males compared to controls (Supplementary information S2). Because addition of 139 
Btk formulation could modify parameters of the fly medium and thus contribute to these effects, we 140 
checked the pH of the dose-responses medium. The presence or dose of the formulation had no 141 
effect (Supplementary information S4). 142 
We observed no change in ER using the same dose range of the Btk Cry-free strain 4D22 (Fig. 143 
1a, 1e; Table 1) and the non-pathogenic Bacillus subtilis (Fig. 1a, Table 1). Addition of Bti 144 
Vectobac® did not affect ER up to 108 CFU/g but reduced it by 89% at 109 CFU/g (~2,000 times the 145 
highest recommended dose for field application; Fig. 1a; Table 1; Supplementary information S1). 146 
DT varied with the dose of Btk 4D22, mainly due to differences between doses other than the 147 
control. DT increased by ~1.5 days at the highest dose of Vectobac® (Fig. 1b; Table 1) and showed 148 
a similar trend with B. subtilis (p = 0.06; Fig. 1b; Table 1). None of these three treatments 149 
influenced dramatically the SR, the slight decrease in male proportion for most of the Vectobac® 150 
doses being due to the higher average sex-ratio for the control dose compared to those for the two 151 
other treatments (Supplementary information S2). 152 
To test whether these effects are generic to Btk formulations, the fly development was 153 
evaluated on two other formulations, Delfin® B (same brand) and Scutello DF (brand Dipel®), at the 154 
critical doses 108 and 109 CFU/g. As Delfin® A, these formulations contain spores and Cry toxins 155 
such as Cry-1A as pro-toxins of ~130 kDa, activated toxins of ~60-70 kDa, but also as smaller 156 
fragments (Wei et al. 2016; Fig. 1e, red asterisks). ER remained unchanged at 108 CFU/g whereas 157 
no individual reached pupation at 109 CFU/g on Delfin® B and very few individuals reached the 158 
adult stage on Scutello DF®, DT being increased by more than 2 days (Fig. 1c-d; Table 1). No 159 
significant bias in SR was observed for either formulation (Supplementary information S2).  160 
 161 
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Adverse effects of Btk formulation strongly impact the early development.  162 
Larval stages were tested for their susceptibility to Btk formulation in two independent and 163 
complementary dose-response tests of survival on Delfin® A, at doses ranging from 105 to 109 164 
CFU/g of high protein/sugar free medium (this medium is used to rear fly species which are 165 
difficult to rear in the lab (see below) and is less limiting for the development of early larval stages). 166 
We focused on the 1st and 2nd larval instars, during which growth is exponential (Tennessen and 167 
Thummel 2011), so that larvae are most heavily exposed to the bioinsecticide. In the first test, the 168 
cumulative survival was measured by counting late 1st and 2nd instar larvae alive which have been 169 
exposed to Delfin® A from the egg stage. Larval survival was not influenced at 107 CFU/g, whereas 170 
it decreased for both larval instars above that dose to reach up to 37% mortality at 109 CFU/g (Fig. 171 
2a). Reduced survival tended to occur at a lower dose when cumulative survival was measured later 172 
in the development, i.e. 109 for late 1st instar larvae and 108 CFU/g for 2nd instar larvae (Fig. 2a; 173 
Table 1). For both instars, larvae surviving 109 CFU/g were noticeably smaller and less active than 174 
those surviving lower doses. In emergence assays with planned exposure from the egg to the adult 175 
stage, none of these individuals reached the pupal stage (see results above). In the second test, larval 176 
survival was measured after early 1st and 2nd instar larvae had been exposed for 24 hours to Delfin® 177 
A. Survival of 1st instar larvae decreased by 36% on 109 CFU/g whereas that of 2nd instar larvae did 178 
not change (Fig. 2b, Table 1).  179 
 180 
Developmental exposure to Btk formulation does not strongly influence fitness-related traits 181 
in adults.  182 
Long-term consequences on flies of exposure to Btk formulation throughout the development were 183 
evaluated on two fitness-related traits, longevity and total offspring number. Traits were measured 184 
on a Btk-free low-protein/high-sugar medium after individuals had completed their development on 185 
the same fly medium but in presence of selected doses of Delfin® A: 5×106 CFU/g, which had no 186 
impact on development, and 5×107 and 108 CFU/g, which caused moderate and strong 187 
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developmental alterations, respectively (see Fig. 1a).  188 
Adult longevity was analysed in two independent experiments on groups of 15 females and 15 189 
males held together. Despite large variation between experiments (Table 1), the longevity of adults 190 
reared on 5×106 CFU/g of Delfin® A was similar to that of non-exposed controls (Fig. 3). Males 191 
and females which developed on the two higher doses showed a moderate longevity benefit, higher 192 
in females for 108 CFU/g (Fig. 3a-b, d-e; Table 1). Males generally survived better than females 193 
(Table 1) but their longevity benefit of developing on 108 CFU/g was only observed in the second 194 
experiment (Fig. 3b, e).  195 
The female offspring number - the sum of offspring produced by the 15 females of each fly 196 
group during the longevity experiment - varied depending on both the experiment and the Delfin® A 197 
dose (Table 1). In the 1st experiment, adults from larvae reared on 108 CFU/g had fewer offspring 198 
compared to control adults and to adults developed on the other doses whereas the total offspring 199 
number varied regardless of the Btk dose in the 2nd experiment (Fig. 3c, f, Table 1).  200 
 201 
Btk-formulation dose-dependent alterations of development are not specific to the D. 202 
melanogaster strain.  203 
Dose-dependent effects of Btk formulation on the development were tested on three additional D. 204 
melanogaster strains: the wild-type Nasrallah (strain 1333), the wild-type Sefra population reared in 205 
the laboratory for 4 years, and the double mutant YW1118. The emergence rates (ER) and 206 
developmental times (DT) were measured on a high-protein/sugar-free medium (rearing medium of 207 
these strains) mixed with Delfin® A doses ranging from 105 to 109 CFU/g. To allow the comparison 208 
with previous results with Canton S flies on low-protein/high sugar fly medium, Canton S was also 209 
reared and tested on the high-protein/sugar-free medium along with the other strains.  210 
None of the fly strains was impacted at doses up to 107 CFU/g, whereas ER was strongly reduced 211 
and DT was increased at higher doses for all the strains (Fig. 4a-b, Table 1), with no individual 212 
reaching the pupal stage at 109 CFU/g (LD50 between 108 and 109 CFU/g). At 108 CFU/g, the 213 
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magnitude of effects on Canton S flies was lower than that observed on the low-protein/high-sugar 214 
medium. At this dose, ER varied between strains, the largest reduction being observed for Sefra 215 
(Table 1). We observed no dose-dependent bias in SR (Supplementary information S3).  216 
 217 
Btk formulation also affects other Drosophila species.  218 
The ER and DT were analysed for seven other Drosophila species from different phylogenetic 219 
clades at doses of Delfin® A from 105 to 109 CFU/g of high-protein/sugar-free medium (rearing 220 
medium of all the species). Tested species were D. simulans (D. melanogaster sister species), the 221 
African D. yakuba, D. subobscura, D. immigrans, D. hydei, and the invasive D. suzukii, all 222 
belonging to the Drosophila subgenus, and D. busckii from the Dorsilopha subgenus. For all the 223 
species, doses up to 106 CFU/g of Delfin® A had no effect on ER and DT whereas all individuals 224 
failed to reach the pupal stage and no fly emerged at 109 CFU/g (Fig. 5-6). Amplitudes of 225 
development alterations at 107 and 108 CFU/g varied between species (Fig. 5-6; Table 1). All 226 
species were affected at 108 CFU/g as was D. melanogaster (see Fig. 4a for comparison). D. 227 
simulans and D. busckii had unchanged ER, but DT was slightly increased for D. simulans 228 
(although slightly reduced at 107 CFU/g; similar results with a Japanese strain, data not shown) and 229 
strongly increased for D. busckii (by 20%, i.e. ~ 4 days) (Fig. 5-6, Table 1). D. yakuba ER and DT 230 
were similar to those of D. melanogaster, with an LD50 around 108 CFU/g and a moderate DT 231 
increase of ~ 1 day (Fig. 5-6, Table 1; similar results with a strain from Sweden, data not shown). 232 
The ER of D. hydei and D. subobscura were very low at 108 CFU/g (LD50 below this dose), with a 233 
high DT (Fig. 5-6; Table 1), while D. immigrans did not survive. No D. suzukii individual emerged 234 
at 108 CFU/g and development was already moderately impacted at 107 CFU/g (Fig. 5-6). No dose-235 
dependent bias in SR was detected for either species (Supplementary information S5).  236 
 237 
Development alterations may result from a synergy between formulation components.  238 
Bt spores and toxins can represent more than half the weight of commercial formulations, with up to 239 
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about 10% of insecticidal protein toxins within this fraction, mainly Cry pro-toxins and activated 240 
toxins (see Fig. 1e) (Koch et al. 2015). The remaining weight consists of various compounds such 241 
as residues of culture medium and various additives including surfactant, anti-foaming agents, etc. 242 
(Glare and O'Callaghan, 2000; Brar et al. 2006). Indeed it has been shown for some products that 243 
additives can be more harmful in some cases than the active ingredient (Bradberry et al. 2004), we 244 
explored the role of small diffusible molecular weight components of Delfin® A in the alterations of 245 
ER and DT of D. melanogaster Canton S. For that, we mixed a 10 kDa dialyzed suspension of 246 
Delfin® A at 107, 108, and 109 CFU/g with low-protein/high-sugar medium. ER and DT were 247 
unaffected by the presence of the dialyzed suspension from the 107 CFU/g dose, whereas no 248 
individual reached the adult stage (no pupation) with the suspension from the 109 CFU/g dose (Fig. 249 
7a; Table 1). At 108 CFU/g, ER was not modified but DT increased by ~ 1 day, only in one of the 250 
two experiments, partially reproducing the changes observed without dialysis (Fig. 7a-b; see also 251 
Fig. 1a-b, Table 1; 3 independent experiments for ER, 2 independent experiments for DT).  252 
Cry1A profiles of dialyzed Delfin® A suspensions, like those of the non-dialyzed ones, 253 
comprised 130-kDa pro-toxins and 60-70 kDa activated toxins, but also showed toxin degradation 254 
as evidenced by additional smaller fragments of activated toxins (Fig. 7c). The respective roles of 255 
Btk toxin fragments and spores in the alterations of D. melanogaster development were further 256 
explored through experiments of dialysis such as those previously described followed by successive 257 
centrifugations to eliminate most of the spores and toxin crystals. Despite variation between 258 
experiments, ER was strongly affected only in one of the three experiments while DT was always 259 
significantly increased when flies were reared in presence of centrifuged supernatants that 260 
contained a limited range of Cry 1A toxin fragments (Supplementary information S6).  261 
 262 
Discussion 263 
The increasing use of bioinsecticides based on Bacillus thuringiensis (Bt) raised concern about 264 
potential side-effects on non-target biodiversity because of their partial specific targeting (de Souza 265 
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Machado et al. 2017; van Frankenhuyzen 2017; Venter and Bohn 2016), persistence in the 266 
environment (Duchet et al. 2014; Hung et al. 2016a, b), and requirement of repeated spraying to 267 
reach the desired pest control level (Brar et al. 2006). Especially, side-effects of chronic exposure 268 
on non-target biodiversity, including insects present on treated areas, remain under-evaluated. Here, 269 
we tested the side-effects of ingestion of Bt formulations (mainly Bt kurstaki (Btk) but also Bt 270 
israelensis (Bti)) throughout the entire development of several non-target species of Drosophila 271 
flies which are naturally present in treated areas. While formulation doses up to those recommended 272 
for field sprayings (≤ 106 CFU/g of medium) had no effect on Drosophila development, mortality 273 
and/or developmental delay occurred from doses only 10 times and 50 times higher than the 274 
maximum recommended dose of the main tested Btk formulation for D. suzukii (107 CFU/g) and the 275 
D. melanogaster strains (5×107 CFU/g), respectively. Besides, all the tested species except D. 276 
simulans were strongly affected at 108 CFU/g, and no (or extremely limited) fly development 277 
occurred at the highest tested dose (109 CFU/g), equivalent to 1000 times the maximum 278 
recommended dose but below common acute intoxication doses (WHO Report, 2007). 279 
Recommended doses are those for each spraying on a homogeneous and dry zone without covering 280 
areas. In the field, both repeated spraying of stabilized formulation and rainfall washouts can 281 
increase Bt spores and toxins presence in both space and time. While the highest dose tested here 282 
would hardly be reached in the field, the minimal doses at which flies development was impacted 283 
may be readily obtained. Furthermore, the minimal quantity of Bt formulation inducing 284 
developmental alterations may be even lower since a single Drosophila larva is unlikely to process 285 
1g of medium given its size and feeding rate. Our data also evidence a window of susceptibility to 286 
Btk during the larval development, ingestion during the 1st larval instar being responsible for a large 287 
part of the observed detrimental effects on the development. 288 
When testing for generic effects of Bt formulations, slightly different results were observed 289 
with two other Btk formulations and a formulation of Bti: there was no effect on D. melanogaster 290 
development at the doses up to 108 CFU/g but a strong detrimental effect at the highest dose tested, 291 
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109 CFU/g. All the Btk formulations, based on two different bacterial strains (see Methods), had 292 
similar profiles of Cry1A protoxins and activated toxins, but they differed in their efficient spore 293 
contents, formulation type, and likely additives, which may account for the observed variation in 294 
the half-lethal dose. The Bti formulation, widely used against Dipteran Nematoceran insects (e.g. 295 
mosquitoes, black flies; Becker 2000), impacted D. melanogaster development only at the highest 296 
dose tested. These impacts of Bt formulations on D. melanogaster development are consistent with 297 
growing evidence suggesting a partly specific targeting of Bt (van Frankenhuyzen 2013; Venter and 298 
Bøhn, 2016). Until recently, it has generally been accepted that the mode of action of Bt after 299 
ingestion by insects relies on key steps of specific binding of proteolyzed Bt toxins to receptors of 300 
midgut epithelial cells, defining targets for each Bt subspecies (Bravo et al. 2007, 2011; Palma et al. 301 
2014). Several primary and secondary types of toxin receptors, including cadherin-like proteins, 302 
aminopeptidases, GPI-anchored alkaline phosphatases (Adang et al. 2014), and more recently the 303 
ATP dependent binding cassette reporter C2 (Stevens et al. 2017), have been identified in 304 
Lepidoptera and Dipteran mosquitoes. Focusing on the action of Btk targeting Lepidoptera, no 305 
Lepidoptera cadherin-like Cry receptor orthologues were found in Drosophila (Stevens et al. 2017), 306 
supporting the idea that these flies would not be affected by the spraying of Btk formulation. The 307 
existence of other types of Cry receptors in Drosophila flies remains to be investigated. In addition, 308 
the substantial amounts of active Cry1A toxin fragments in Btk formulations could compensate for 309 
the possible lack of solubilization of protoxin crystals in the fly midgut and proteolytic activation of 310 
toxins by fly gut proteases, both required for Cry activity in insect larvae (Bravo et al. 2007). Other 311 
toxins synthesized by Btk and present in the formulations could also play a role in the observed 312 
cross-order activity as some, such as Cry2A, have an insecticidal effect on both Lepidoptera and 313 
Diptera (George and Crickmore 2012). 314 
The lack of effect of ingestion of Bacillus subtilis or Btk Cry-free 4D22 on the development 315 
of D. melanogaster excludes that developmental alterations result from severe disruption of 316 
digestion and nutrient uptake/competition in the presence of high spore/bacteria loads in the larval 317 
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gut throughout development. It supports the idea of a synergistic action of Btk spores and Cry 318 
toxins, consistent with the models of Bt action on insect larvae in which toxins first breach the gut 319 
epithelium, allowing the gut content, including Bt spores, to colonize the hemocoel (Bravo et al. 320 
2007; Obata et al. 2009; Bravo et al. 2011; Caccia et al. 2016). The partially reproduced mortality 321 
rate and delayed development in dialysis experiments further indicate that low diffusible molecular 322 
weight compounds in Btk formulations (e.g., culture media residues, salts, additives) may contribute 323 
to these developmental alterations. This is supported by the lack of impact on D. melanogaster 324 
development of the ingestion of laboratory-produced spores and Cry toxins of a Btk 4D1 strain (or 325 
HD1, a reference strain used as a control strain, not used in the commercial formulations) used 326 
without additives, even at the highest dose 109 CFU/g (additional information S7; Fig. S7a, b). The 327 
Btk 4D1 culture contained few active Cry toxins and smaller toxin fragments, in contrast to 328 
commercial Btk formulations (Fig. S7c), supporting the possible contribution of these toxin 329 
fragments to the cross-order activity of Btk formulations on Drosophila.  330 
As observed for D. suzukii exposed to laboratory-produced Btk cultures (Cossentine et al. 331 
2016), mortality of D. melanogaster during development on Btk formulation already occurred early 332 
in development. First and second instars larvae are probably highly exposed due to their high 333 
feeding rate and their exponential growth (Santos et al. 1997). As the observed larval mortality was 334 
only about 40% at the highest dose (109 CFU/g) (Figure 2), while none of the individuals reached 335 
the pupal stage at this dose (Figure 4), the remaining mortality likely occurred during the third 336 
larval stage, maybe due to delayed action of Btk spores and toxins. Interestingly, alterations of the 337 
development (mortality and delayed emergence) mimicked those typically generated by nutritional 338 
stress conditions in insect larvae (Nepoux et al. 2010; Vantaux et al. 2016). Accordingly, the 339 
developmental alterations were partially rescued on a protein rich fly medium, probably through 340 
compensatory protein intake, as in other arthropod species (Moret and Schmid-Hempel 2000; 341 
Kutzer and Armitage 2016; Vantaux et al. 2016). In addition, the sex ratio of flies was strongly 342 
biased towards males after development on the dose of Btk formulation affecting fly emergence (108 343 
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CFU/g) and under low protein conditions. This highlights the importance of nutritional conditions 344 
in Btk impacts on development, with sex-specific differences in larval susceptibility to 345 
environmental stressors, here the accumulation of Btk formulation, under protein restriction 346 
conditions as previously reported in D. melanogaster (Andersen et al. 2010).  347 
The development on sublethal doses of Btk formulation did not dramatically affect the 348 
longevity of D. melanogaster adults and the offspring number throughout life. Developmental 349 
exposure to Btk doses that slightly and strongly reduced the likelihood of reaching the adult stage 350 
even gave males and females a dose-dependent longevity benefit, in addition to the male higher 351 
longevity observed in mixed-sex populations (Khazaeli and Curtsinger, 2000), and slightly 352 
increased the offspring number (although not significantly). Surviving the exposure to Btk 353 
formulation throughout the development has likely selected for fitter individuals. This is similar to 354 
the increased longevity of adult insects that have survived developmental nutritional stress (Rion 355 
and Kawecki, 2007, Burger et al. 2010), or are resistant to environmental stressors (Khazaeli and 356 
Curtsinger 2000). 357 
 The origin of Drosophila (species and population/strain) influenced the magnitude of the 358 
impacts of the Btk formulation on the development. Within the D. melanogaster species, all strains 359 
tested were susceptible to the Btk formulation with both mortality and delayed development at the 360 
same dose, but with variation in the effect magnitude. This suggests potential population-specific 361 
differences in susceptibility to Btk formulation accumulation in the environment, and hence 362 
potential spatial and temporal heterogeneity of Btk spraying impacts for each Drosophila species. 363 
At the fly community level, differences in susceptibility to Btk formulation, in terms of effect 364 
magnitude and type of developmental alteration (mortality and/or developmental delay) occurred 365 
between Drosophila species, regardless of their phylogenetic distances. In the Drosophila 366 
subgenus, D. simulans was less susceptible than its sister species D. melanogaster, whereas the 367 
African D. yakuba experienced similar impacts on the development as D. melanogaster. The three 368 
species D. immigrans, D. subobscura and D. hydei were similarly more susceptible than D. 369 
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melanogaster, but with slight differences in effect magnitudes. The phylogenetically distant D. 370 
busckii (Dorsilopha subgenus) was the least affected of all the species tested in terms of 371 
developmental mortality, but its development was strongly delayed. The five species D. 372 
melanogaster, D. simulans, D. hydei, D. immigrans, and D. busckii belong to the guild of 373 
cosmopolitan domestic Drosophila species, D. subobscura is sub-cosmopolitan species, and D. 374 
busckii is an opportunistic frugivorous species (Atkinson and Shorrocks 1977). All these species 375 
coexist frequently and compete on the same discrete and ephemeral rotting fruit patches, with 376 
seasonal variations in the composition of the fly community (Shorrocks 1991; Benado and Brncic 377 
1994; Nunney 1996; Mitsui and Kimura 2000). Differences in species susceptibility to 378 
accumulation of Btk formulation could modify larval competition conditions and lead to additional 379 
local and temporal variations in Drosophila communities’ composition. The potential side-effects 380 
of Bt sprays on non-target Drosophila communities would be hardly predictable as they depend on 381 
spatial patterns of Bt accumulation.  382 
The Btk formulation clearly impacted the development of the invasive D. suzukii, as recently 383 
reported by Cossentine et al. (2016), this species being the most susceptible here with effects 384 
already detectable at 10 times the recommended spraying dose. Compared with the other seven 385 
species that live on rotten fruits, D. suzukii poses a threat to fruit production because it feeds and 386 
lays eggs on healthy ripening fruits (Walsh et al. 2011; Delbac et al. 2014; Poyet et al. 2014) and 387 
hence colonizes orchards and vineyards earlier during the fruit season. The greater susceptibility of 388 
D. suzukii to the accumulation of Btk formulation in the environment might mitigate the potential 389 
ecological burden of its invasion for local communities of Drosophila frugivorous species in 390 
orchards. Alternatively, as D. suzukii attacks on fruits can accelerate their decomposition by 391 
microorganisms, its higher susceptibility to Btk could reduce the number of fruits made suitable for 392 
other Drosophila species.  393 
In conclusion, we show here that repeated spraying and accumulation of Btk formulation  394 
can potentially impact non-target insect communities, and the magnitude of this impact could 395 
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depend on the formulation used and the insect species. Recent studies have reported similar adverse 396 
side-effects due to repeated spraying of the Bti formulation, directly on non-target organisms (e.g. 397 
Duguma et al. 2015), and indirectly on predators via food webs (e.g. Poulin et al. 2010). These 398 
studies and the data presented here highlight that pest control with Bt bioinsecticides should be done 399 
with caution in the field to avoid, or at least limit, potential negative impacts on non-target 400 
biodiversity and species communities within ecosystems. At last, D. melanogaster, a model species 401 
in many research fields, could also serve as a study model to assess the toxicity of Bt on non-target 402 
species, and identify the mechanisms underlying these side-effects.  403 
 404 
Methods 405 
Commercial formulations, Bacillus productions and Colony Forming Unit measurement 406 
The tested commercial brands of Bacillus thuringiensis kurstaki (Btk; serotype 3a, b, c; Zeigler, 407 
1999) were Delfin® A and B (strain SA11; wettable granules, Valent BioSciences, AMM 9200482, 408 
32,000 UI/mg) and Scutello DF (a Dipel® sub-brand; strain ABTS-351; wettable granules, Biobest®, 409 
AMM 2010513, 540g/kg). The commercial brand of Bacillus thuringiensis israelensis (Bti; strain 410 
HD-14; serotype 14; Ziegler, 1999) was VectoBac® WG (wettable granules, Bayer, AMM 2020029, 411 
3000 UTI/mg). For each formulation, the number of viable spores (expressed as Colony Forming 412 
Units (CFU) per mg of granules) was estimated using serial dilutions of a suspension on LB agar 413 
plates and counting of bacterial colonies after overnight incubation at 30°C. CFU estimations were 414 
5×107 CFU/mg for Btk Delfin® A; 2.5×107 CFU/mg for Btk Delfin® B; 2.2×107 CFU/mg for Btk 415 
Scutello DF; 6×107 CFU/mg for Bti VectoBac®. No change in CFU estimations occurred during the 416 
time frame of the experiments. Manufacturer-recommended doses for Delfin® range from 0.15 to 417 
1.5 kg/ha depending on the crop type. Based on our CFU estimations, this corresponds to 418 
recommended doses of 7.5×104 to 7.5×105 CFU/cm2 of Delfin® A, and 3.75×104 to 3.75×105 419 
CFU/cm2 of Delfin® B for each spraying in the field. For Scutello DF, recommended doses range 420 
from 0.1 to 1 kg/ha, equivalent to 2.2×104 to 2.2×105 CFU/cm2. Vectobac® WG is used at 0.125 to 421 
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1 kg/ha, equivalent to 7.5×104 to 6×105 CFU/cm2. 422 
The acrystillipherous (Cry toxin-free) Btk 4D22 strain (depleted for the toxin-encoding 423 
plasmids; Gonzalez et al. 1982) obtained from the Bacillus Genetic Stock Center (http://bgsc.org; 424 
Columbus USA), and a Drosophila non-pathogenic Bacillus subtilis (gift from Dr. E. Bremer, 425 
University of Marburg, Germany; A. Brun-Barale, pers. comm.) were grown at 30°C in the 426 
sporulation-specific medium PGSM (Bactopeptone® 7.5 g, KH2PO4 3.4 g, K2HPO4 4.35 g, glucose 427 
7.5 g, PGSM salts 5 mL, CaCl2 0.25 M, distilled water qsp 1L, pH 7.2; PGSM salts: MgSO4.7H2O, 428 
MnSO4.H2O, ZnSO4.7H2O, FeSO4.7H2O) for about 14 days for sporulation to occur. Following 429 
elimination of vegetative cells (1h at 70 °C), spore pellets were collected after centrifugation (4,500 430 
rpm, 20 min, 4 °C), washed with sterile water, and lyophilized. CFU numbers were counted for 431 
each preparation as described above. 432 
 433 
Fly stocks 434 
The four tested strains of Drosophila melanogaster (phylogenetic subgroup: melanogaster) were the 435 
standard wild-type Canton S (Bloomington Drosophila Centre) used as a reference strain, the wild-436 
type Nasrallah strain from Tunisia (strain 1333, Gif-sur-Yvette), the double mutant standard strain 437 
YW1118 (white and yellow mutations; gift from Dr. B. Charroux, IBD, Marseille-Luminy), and a 438 
recently field-collected strain (caught in Southern France in 2013) that we named “Sefra”. For 439 
Drosophila species comparison, we included 6 species of the Drosophila subgenus, D. simulans 440 
(strain 1132; phylogenetic subgroup: melanogaster), D. yakuba (strain 1880; phylogenetic subgroup: 441 
melanogaster), D. hydei (phylogenetic subgroup: hydei) and D. suzukii (phylogenetic subgroup: 442 
immigrans) (both kindly provided by Dr. R. Allemand, LBBE, University Lyon 1), D. immigrans 443 
(phylogenetic subgroup: immigrans), D. subobscura (phylogenetic subgroup: obscura), and one 444 
species of the Dorsilopha subgenus, D. busckii (all three species collected in South-East of France 445 
in Spring 2015). 446 
All strains and species were maintained at controlled densities (150-200 eggs/40 ml of fly 447 
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medium) under standard laboratory conditions (25°C or 20°C for recently collected species, 60 % 448 
relative humidity, 12:12 light/dark cycle), on a high-protein/sugar-free fly medium (10 % cornmeal, 449 
10 % yeast, 0 % sugar). The D. melanogaster Canton S strain was also reared on a standard low-450 
protein/sugar-free fly medium (8 % cornmeal, 2 % yeast, 2.5 % sugar) to test for the influence of 451 
the medium composition on Btk exposure effects.  452 
 453 
Intoxication method and dose-response assay 454 
Commercial formulations and laboratory spore productions were suspended and diluted in buffer to 455 
perform dose-response assays with doses from 105 to 10⁹ CFU/g of fly medium. All doses were 456 
prepared in 100 µl and homogenized thoroughly with the fly medium (100µl/g). Drosophila eggs 457 
and larvae were collected from stock vials at the suitable developmental stage and transferred 458 
carefully to the intoxication vials and dishes, then maintained under standard laboratory conditions 459 
until a) the emergence of adults, or, in the larvae survival tests, b) until a given developmental stage 460 
was reached from the egg, and c) for 24h. Control groups of individuals were transferred on fly 461 
medium homogenized with the same volume of buffer. 462 
 463 
Development-related traits and larval survival 464 
To evaluate emergence rates and developmental times upon intoxication throughout the entire 465 
development, precise numbers of eggs from mass oviposition were transferred to intoxication vials 466 
containing fly medium mixed with doses of Bt formulations or bacteria productions and let to 467 
develop under standard laboratory conditions until the fly emergence. Eggs without chorion and 468 
transparent eggs were discarded. The initial number of eggs was adjusted depending on the species 469 
biology and the vial size: 20 eggs for 2 g of fly medium in small vials (Ø 3.3 cm, surface ~8.5 cm2, 470 
0.24 g/cm2) for tests with D. melanogaster Canton S, 50 eggs for 6 g of fly medium for comparison 471 
of D. melanogaster strains and Drosophila species in wider vials (Ø 4.6 cm, surface ~16 cm2, 0.37 472 
g/cm2) except for D. hydei, D. suzukii and D. immigrans for which 30 eggs were transferred on 6 g 473 
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of fly medium. Numbers and sex of emerging flies were recorded once a day until the day the pupae 474 
of the next generation should form. From these data, the emergence rate (proportion of emerged 475 
flies from the initial eggs; ER), the mean developmental time (mean number of days for completion 476 
of development; DT), and the sex-ratio (proportion of male flies; SR) were calculated for each 477 
intoxication vial.   478 
For the larval survival tests, 20 eggs or larvae from a 4-hour mass oviposition at the indicated 479 
developmental stage, were transferred to small dishes containing 1 g of fly medium (Ø 3 cm, 480 
surface ~7 cm2) homogenized with increasing doses of Delfin® A. Surviving larvae were counted at 481 
the indicated developmental stage, or after 24-hour intoxication, to calculate the proportion of 482 
surviving larvae. For the test from the egg, eggs which did not hatch were not included in the 483 
counting. As a control measurement, we measured the pH of the fly medium in the presence of the 484 
dose range of Bt formulations (see Supplementary Information S4).  485 
 486 
Adult fitness-related traits 487 
For the longevity and offspring number tests, males and females emerged from several rearing vials 488 
for each dose of Delfin® A were pooled when aged 2 days. Groups of 15 males and 15 females were 489 
transferred into vials with fresh fly medium without formulation. Fly medium was renewed every 3-490 
4 days. After each fly transfer to fresh food, discarded maintenance vials were incubated under 491 
standard laboratory conditions for the offspring to develop. Mortality and sex of dead flies were 492 
recorded daily until the last fly died. Offspring numbers were counted from the first emergence 493 
until pupae of the next generation appeared. The tests were repeated twice. Due to the variation in 494 
the duration of the two longevity experiments, offspring numbers of each vial were summed to 495 
obtain a total offspring number per dose of Delfin® A for each experiment. 496 
 497 
Dialysis and Cry toxin analysis 498 
A suspension of 2×1010 CFU of Delfin® A was dialyzed against PBS (KH2PO4 1.06 mM, 499 
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Na2HPO4(2H2O) 3mM, NaCl 154 mM, qsp distilled water, pH 7.2), at 250 rpm, 4°C overnight, 500 
using an 8-10 kDa MW cut-off membrane (ZelluTrans, Roth®). The CFUs of the dialyzed 501 
suspension and the effects on ER and DT were analysed as described above. The dialyzed 502 
suspension was also subject to a 12.5 % SDS-PAGE and compared to the non-dialyzed suspension 503 
after silver staining. The presence of Cry1A pro-toxins, activated toxins and toxin fragments was 504 
probed by Western-blot using an in-house anti-Cry1A rabbit polyclonal antibody. 505 
 506 
Data analysis 507 
Data on development traits (emergence rate ER and developmental time DT), sex-ratio (SR), 508 
survival of larval stages and offspring number were analysed with mixed effect models including 509 
the dose of Btk formulation/spore production, the D. melanogaster strain, the Drosophila species or 510 
the developmental stage as fixed effects, and replicate (plus the experiment when necessary) as 511 
random effects (for ER data, data were analysed with bias-corrected models with replicate as fixed 512 
effect to allow pairwise comparisons; similar results obtained with models including replicate as 513 
random effect). ER, SR and survival of larval stages were analysed with generalized linear models, 514 
with binomial distribution and logit link. DT and offspring number were analysed with linear 515 
models. DT were transformed into developmental rates (1/developmental time) to fulfil the 516 
assumptions of the analysis of variance (homoscedasticity and residuals normality). Adult longevity 517 
data were analysed with proportional hazard Cox regression models including fly sex and dose of 518 
Btk formulation as fixed effects, and replicates as a random effect. For all the data sets, the main 519 
fixed effects and their interactions were tested with log-likelihood ratio tests. Post hoc pairwise 520 
comparisons were made for pairs of D. melanogaster strains, formulation/spore treatments, and 521 
between the control dose and the other doses. All the analyses were performed in R (R 522 
Development Core Team, 2008) using the packages lme4 (Bates et al. 2015), brglm (Kosmidis 523 
2017), multcomp (Horton et al. 2008), survival (Terry et al. 2000) and coxme (Terry and Therneau, 524 
2015). 525 
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Source of variation/Data χ2 / Deviance d.f. P value 
Development on Btk Delfin® A, Btk 4D22, Bti Vectobac®, Bacillus subtilis 
Emergence rate 
Dose × Treatment  285.7 20 < 0.0001 
Dose for each treatment: 
- Delfin® A 237.5 6 < 0.0001 
- 4D22 7.0 7 0.40 
- Vectobac® 165.8 5 < 0.0001 
- B. subtilis 1.9 6 0.93 
    
Developmental time    
Dose × Treatment 220.8 19 < 0.0001 
Dose for each treatment: 
- Delfin® A 68.8 6 < 0.0001 
- 4D22 16.08 7 0.024 
- Vectobac® 37.5 6 < 0.0001 
- B. subtilis 13.5 7 0.060 
Development on Btk Delfin® B and Scutello DF (dose effect) 
Emergence rate    
- Delfin® B 151.2 2 < 0.0001 
- Scutello DF 105.1 2 < 0.0001 
    
Developmental time    
- Delfin® B 2.5 1 0.12 
- Scutello DF 30.9 2 < 0.0001 
Role of formulation components in the development alterations (dialysis) 
Dose effect    
Emergence rate 459.8 3 < 0.0001 
Developmental time 13.7 2 0.0011 
Survival of larval stages on Delfin® A  
Cumulative survival   
Dose × Larval instar  16.2 5 0.0063 
Dose for each instar:    
- late 1st instar 87.4 5 < 0.0001 
- late 2nd instar 25.7 5  0.0001 
    
24-hour survival    
Dose × Larval instar  15.9 5 0.007 
Dose for each instar: 
- late 1st instar 55.9 5 < 0.0001 
- late 2nd instar 3.76 5 0.58 
Adult fitness-related traits after development on Delfin® A 
Longevity    
Experiment 20.1 1 < 0.0001 
    
- 1st experiment: 
Dose 12.3 3 0.0065 
Sex 35.0 1 < 0.0001 
  (eβ coefficient males vs females ± se: 0.55 ± 0.16) 
Dose × Sex 20.4 3 0.00014 
 
Sexes analyzed separately 
     - females 12.0 3 0.0073 
      (eβ coefficients vs control ± se: 5×106: 1.05 ± 0.17, 5×107: 0.71 ± 0.16, 108: 0.60 ± 0.21) 
     - males 20.4 3 0.00014 
     (eβ coefficients vs control ± se: 5×106: 0.80 ± 0.16, 5×107: 0.66 ± 0.16, 108: 1.53 ± 0.18) 
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Source of variation/Data χ2 / Deviance d.f. P value 
Adult fitness-related traits after development on Delfin® A 
 - 2nd experiment: 
Dose 16.5 3 0.00090 
Sex 31.5 1 < 0.0001 
  (eβ coefficient males vs females ± se: 0.45 ± 0.22) 
Dose × Sex 0.69 3 0.88 
 
Sexes analyzed separately 
     - females 13.2 3 0.0043 
      (eβ coefficients doses vs control ± se: 5×106: 0.92 ± 0.22, 5×107: 0.63 ± 0.21, 108: 0.51 ± 0.21) 
     - males 7.01 3 0.072 
      (eβ coefficients doses vs control ± se: 5×106: 1.02 ± 0.22, 5×107: 0.70 ± 0.22, 108: 0.64 ± 0.22) 
    
Total numbers of offspring 
Dose × Experiment                                28.1                                        3                                     < 0.0001 
 
Dose for each experiment: 
- 1st experiment 26.3 3 < 0.0001 
- 2nd experiment 4.1 3 0.25 
Development of other strains of D. melanogaster on Delfin® A (including Canton S) 
Emergence rate     
Dose × Fly strain 105.5 15 < 0.0001 
Dose for each fly strain: 
- Canton S 588.6 5 < 0.0001 
- Nasrallah 745.3 5 < 0.0001 
- Sefra 900.7 5 < 0.0001 
- YW1118 636.9 5 < 0.0001 
    
Developmental time    
Dose × Fly strain 9.3 12 0.68 
Dose for each fly strain: 
- Canton S 40.3 4 < 0.0001 
- Nasrallah 18.0 4 0.0012 
- Sefra 27.2 4 < 0.0001 
- YW1118 28.9 4 <0.0001 
Development of other Drosophila species on Delfin® A 
Emergence rate    
Dose × Fly species 538.2 30 < 0.0001 
Dose for each species: 
- D. simulans 461.0 5 < 0.0001 
- D. yakuba 750.7 5 < 0.0001 
- D. hydei 596.8 5 < 0.0001 
- D. immigrans 726.3 5 < 0.0001 
- D. subobscura 729.6 5 < 0.0001 
- D. suzukii 725.0 5 < 0.0001 
- D. busckii 586.0 5 < 0.0001 
    
Developmental time    
Dose × Fly species 59.9 22 < 0.0001 
Dose for each species: 
- D. simulans 25.9 4 < 0.0001 
- D. yakuba 34.7 4 < 0.0001 
- D. hydei 11.5 4 0.022 
- D. immigrans 6.01 3 0.11 
- D. subobscura 68.8 4 < 0.0001 
- D. suzukii 11.7 3 0.0085 
- D. busckii 58.8 4 < 0.0001 
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Figure legends 766 
Figure 1. Development of D. melanogaster Canton S flies on Btk and Bti commercial 767 
formulations. (a) Emergence rate (mean ± sem) and (b) developmental time (mean ± sem) of 20 768 
initial eggs on increasing doses of Btk Delfin® A (red triangles), the Cry-free Btk 4D22 (open 769 
lozenges), the mosquito-targeting Bti Vectobac® (green squares), and the non-pathogenic Bacillus 770 
subtilis (light grey circles). For Vectobac® and B. subtilis, N = 4-7 per dose; for Delfin® A and Btk 771 
4D22, N = 9-12 for the control, N = 3 for 5.105 and 109, N = 4-9 for 106, N = 7-14 from 5.106 to 108. 772 
(c) Emergence rate (mean ± sem) and (d) developmental time (mean ± sem) on increasing doses of 773 
the two Btk formulations Delfin® B (dark red circles) and Scutello DF (orange squares). N = 4 774 
replicates of 20 eggs per dose and formulation, except for controls and 108 CFU/g of Delfin® B (9-775 
10 replicates of 20 eggs). Results of post hoc comparisons of each dose to the control: . 0.05<p<0.1; 776 
* 0.01<p<0.05; ** 0.001<p<0.01; *** p<0.001. (e) Immunoblotting with an anti-Cry1A polyclonal 777 
antibody on proteins from a suspension of laboratory-produced spores of Cry-free Btk 4D22, the 778 
three Btk formulations Delfin® A, B, Scutello DF, and a suspension of laboratory-produced Cry1A 779 
toxins. Red asterisks indicate the Cry protoxins (~130 kDa) and the activated fragments (~60 kDa 780 
and ~70 kDa).   781 
 782 
Figure 2. Survival of D. melanogaster Canton S larval stages on increasing doses of Btk 783 
Delfin® A. (a) Proportion of surviving larvae (mean ± sem) upon Btk exposure from the egg to late 784 
1st instar (open lozenges) and late 2nd instar (black triangles). (b) Proportion of surviving larvae 785 
(mean ± sem) upon 24-hour Btk exposure of early 1st instar larvae (open lozenges) and 2nd instar 786 
larvae (black triangles). N = 5-7 replicates of 20 individuals per dose. Results of post hoc 787 
comparisons of each dose with the control: * 0.01<p<0.05; ** 0.001<p<0.01; *** p<0.001.  788 
 789 
Figure 3. Fitness-related traits of adults (longevity and total offspring number) after 790 
development on Btk Delfin® A. (a, d) Female longevity (mean survival fraction over time ± sem), 791 
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(b, e) Male longevity (mean ± sem), and (c, f) total offspring number (mean ± sem), measured on 792 
individuals that developed without Btk (blue items) and on 5×106 CFU/g of Btk Delfin® A (green 793 
items), 5×107 CFU/g (red items), and 108 CFU/g (dark red items). Data from 2 experiments (a-c, 794 
experiment 1; d-f, experiment 2). For each trait, N = 3-5 replicates of 15 males and 15 females per 795 
dose in experiment 1, N = 3 replicates of 15 males and 15 females in experiment 2. Results of post 796 
hoc comparisons of each dose with the control: * 0.01<p<0.05; ** 0.001<p<0.01; *** p<0.001.  797 
 798 
Figure 4. Development of four D. melanogaster strains on increasing doses of Btk Delfin® A. (a) 799 
Emergence rate (mean ± sem), (b) Developmental time (mean ± sem) of the strains Canton S (blue 800 
lozenges), Nasrallah (yellow triangles), Sefra (green squares), and YW1118 (red circles). N = 4 801 
groups of 50 eggs per dose and fly strain for each trait. Results of post hoc comparisons of each 802 
dose to the control: . 0.05<p<0.1; * 0.01<p<0.05; ** 0.001<p<0.01; *** p<0.001.  803 
 804 
Figure 5. Emergence rate of seven Drosophila species on increasing doses of Btk Delfin® A. 805 
Mean emergence rate (± sem). N = 4 replicates of 50 eggs per dose for D. simulans, D. yakuba, D. 806 
subobscura, and D. busckii, N = 4 replicates of 30 eggs per dose for D. hydei, D. suzukii, and D. 807 
immigrans. Results of post hoc comparisons of each dose with the control: . 0.05<p<0.1; * 808 
0.01<p<0.05; ** 0.001<p<0.01; *** p<0.001.  809 
 810 
Figure 6. Developmental time of seven Drosophila species on increasing doses of Btk Delfin® A. 811 
Mean developmental time (± sem). N = 4 replicates of 50 eggs per dose for D. simulans, D. yakuba, 812 
D. subobscura, and D. busckii, N = 4 replicates of 30 eggs per dose for D. hydei, D. suzukii, and D. 813 
immigrans. Results of post hoc comparisons of each dose with the control: * 0.01<p<0.05; ** 814 
0.001<p<0.01; *** p<0.001.  815 
 816 
  817 
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36 
 
Figure 7. Evaluation of the role of small molecular weight components of Btk Delfin® A 818 
(dialysis; membrane cut-off: 8-10 kDa) in the altered development of D. melanogaster Canton 819 
S. (a) Emergence rate (mean ± sem) and (b) developmental time (mean ± sem) on increasing doses 820 
of dialyzed Delfin® A. N = 3 experiments of 4 replicates with 20 eggs per dose for the emergence 821 
rate, N = 2 experiments of 4 replicates per dose for the developmental time. Results of post hoc 822 
comparisons of each dose with the control: . 0.05<p<0.1; * 0.01<p<0.05; ** 0.001<p<0.01; *** 823 
p<0.001. (c) Anti-Cry1A probed immunoblot of non-dialyzed (ND) and dialyzed (D) suspensions 824 
showing the decrease in the amount of ~ 130 kDa protoxins and the increase in that of ~ 60/70 kDa 825 
activated toxins after dialysis.  826 
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